National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Prevention and Cessation of Cigarette Smoking: Control of Tobacco Use (PDQ®)
Patient VersionHealth Professional VersionLast Modified: 05/01/2008
Table 3. Nicotine Lozenges

  Brand  Dose  Side Effects  Comments 
d = day; h = hour; OTC = over the counter; wk = week.
OTC Commit 40–80 mg/d Local irritation (warmth and tingling) Use for 12 wk; max 20 pieces/d. Wk 1–6: 1–2 lozenges every 1–2 h; wk 7–9: 1 lozenge every 2–4 h; wk 10–12: 1 lozenge every 4–8 h


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov